Continue Reading
Full article on Unknown
State Street's crypto push, FDA delays review of Eli Lilly GLP-1
Market Intelligence Analysis
AI-Powered
Why This Matters
State Street is expanding its services into crypto and tokenized assets, while the FDA has delayed its review of several drugs from Eli Lilly, Sanofi, and Disc Medicine, impacting healthcare stocks.
Market Impact
Market impact analysis based on neutral sentiment with 70% confidence.
Sentiment
Neutral
AI Confidence
70%
Time Horizon
Short Term
Article Context
Note: This is a brief excerpt for context. Click below to read the full article on the original source.
Yahoo Finance Host Josh Lipton tracks today's top moving stocks and biggest market stories in this Market Minute, including State Street's (STT) push into crypto and tokenized assets products and healthcare stocks Eli Lilly (LLY), Sanofi (SNY), and Disc Medicine (IRON) after Reuters reports the US Food and Drug Administration (FDA) delayed its review for several drugs. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute.
Original article published by
Unknown
on January 15, 2026.
Analysis and insights provided by AnalystMarkets AI.
Analysis and insights provided by AnalystMarkets AI.